New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 13, 2012
08:05 EDTINSMInsmed completes enrollment for Clear-108 Phase 3 study of Arikace
Insmed announced that the Company's CLinical Evaluation of Arikace phase 3 European and Canadian registrational study of Arikace for Cystic Fibrosis patients with Pseudomonas aeruginosa lung infections has now enrolled over 300 patients.
News For INSM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for INSM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use